Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
作者信息
Shenoy Niraj
机构信息
Mayo Clinic, 200 1st street SW, Rochester 55902, Minnesota, USA.
出版信息
Chin J Cancer Res. 2017 Apr;29(2):166-167. doi: 10.21147/j.issn.1000-9604.2017.02.10.
Abstract
摘要
相似文献
1
Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
Chin J Cancer Res. 2017 Apr;29(2):166-167. doi: 10.21147/j.issn.1000-9604.2017.02.10.
2
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
J Urol. 2010 Feb;183(2):743-51. doi: 10.1016/j.juro.2009.09.086.
3
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
J Cancer. 2019 Oct 22;10(26):6726-6737. doi: 10.7150/jca.35641. eCollection 2019.
4
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
J Urol. 2007 Apr;177(4):1258-63. doi: 10.1016/j.juro.2006.11.100.
5
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
Oncotarget. 2017 Jan 17;8(3):5268-5280. doi: 10.18632/oncotarget.14134.
6
Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways.
Am J Pathol. 2012 Apr;180(4):1675-87. doi: 10.1016/j.ajpath.2011.12.030. Epub 2012 Feb 9.
7
Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
J Urol. 2010 Aug;184(2):731-7. doi: 10.1016/j.juro.2010.03.108. Epub 2010 Jun 19.
8
miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
J Urol. 2011 Sep;186(3):1077-83. doi: 10.1016/j.juro.2011.04.110. Epub 2011 Jul 23.
9
Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Int J Mol Sci. 2015 May 11;16(5):10636-49. doi: 10.3390/ijms160510636.
10
Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Clin Genitourin Cancer. 2017 Dec;15(6):e923-e933. doi: 10.1016/j.clgc.2017.05.016. Epub 2017 May 25.
本文引用的文献
1
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective.
Ann Oncol. 2016 Sep;27(9):1685-95. doi: 10.1093/annonc/mdw241. Epub 2016 Jun 20.
2
Role of DNA methylation in renal cell carcinoma.
J Hematol Oncol. 2015 Jul 22;8:88. doi: 10.1186/s13045-015-0180-y.
3
VHL, the story of a tumour suppressor gene.
Nat Rev Cancer. 2015 Jan;15(1):55-64. doi: 10.1038/nrc3844.
4
Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.
Chin J Cancer Res. 2014 Aug;26(4):371-81. doi: 10.3978/j.issn.1000-9604.2014.08.03.
5
Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.
Clin Cancer Res. 2014 Aug 15;20(16):4349-60. doi: 10.1158/1078-0432.CCR-14-0494. Epub 2014 Jun 10.
6
Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.
Hum Mol Genet. 2014 Apr 15;23(8):2176-88. doi: 10.1093/hmg/ddt614. Epub 2013 Dec 2.
7
Comprehensive molecular characterization of clear cell renal cell carcinoma.
Nature. 2013 Jul 4;499(7456):43-9. doi: 10.1038/nature12222. Epub 2013 Jun 23.
8
Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.
BMC Cancer. 2005 Jun 2;5:57. doi: 10.1186/1471-2407-5-57.
Zotero 插件